L'hôpital Bichat-Claude-Bernard est un centre hospitalier universitaire de l'Assistance publique - Hôpitaux de Paris situé au 46, rue Henri-Huchard dans le 18ᵉ arrondissement de Paris. L'hôpital est rattaché à l'université Paris-Cité et a pour bâtiment voisin la faculté de médecine Paris Nord de l'université.

During the past decade, Bichat Hospital conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 5 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 2 clinical trials were completed. i.e. 3.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bichat Hospital" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 33 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 12 trials sponsored, "Gilead Sciences" with 6 trials sponsored, "French Cardiology Society" with 5 trials sponsored and "Hospices Civils de Lyon" with 5 trials sponsored. Other sponsors include 71 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bichat Hospital" #1 collaborator was "Ministry of Health, France" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator and "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Bichat Hospital" are "HIV Infections" (9 trials), "Non Small Cell Lung Cancer Metastatic" (6 trials), "Acute Myocardial Infarction" (4 trials), "Cardiovascular Diseases" (4 trials) and "Asthma" (3 trials). Many other conditions were trialed in "Bichat Hospital" in a lesser frequency.

Most popular intervention types in "Bichat Hospital" are "Drug" (55 trials), "Other" (26 trials), "Device" (14 trials), "Procedure" (14 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (4 trials), "Placebo" (4 trials), "ATV" (3 trials), "FTC/TDF" (3 trials) and "RTV" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bichat Hospital" are 132 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 55 active trials in "Bichat Hospital". 7 are not yet recruiting, 36 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 64 completed trials in Bichat Hospital, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Bichat Hospital, 1 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 33 trials that are defined as “Not Applicable".